Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

Oral Pharmaceutical Form of Losartan

Paliperidone sustained release formulation

Drug delivery system

PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY

ELECTROSPRAYING METHOD FOR FABRICATION OF PARTICLES AND COATINGS AND TREATMENT METHODS THEREOF

Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same

Gastroresistant pharmaceutical formulations containing rifaximin

MICROENCAPSULATING COMPOSITIONS, METHODS OF MAKING, METHODS OF USING AND PRODUCTS THEREOF

Particulate Compositions Comprising Alginate and/or Alginic Acid

Pharmaceutical composition containing coated, floating particles

Modified release solid or semi-solid dosage forms

Solid form

Stable digestive enzyme compositions

Orally disintegrable tablets

MULTI-MEMBRANE IMMUNOISOLATION SYSTEM FOR CELLULAR TRANSPLANT

NOVEL METHODS OF TREATMENT AND DELIVERY MODES

Methods of producing stable pancreatic enzyme compositions

CONTROLLED RELEASE POTASSIUM CHLORIDE TABLETS

GELS FOR ENCAPSULATION OF BIOLOGICAL MATERIALS

Stable pancreatic enzyme compositions

Controlled-release galantamine formulations

MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist

Pharmaceutical compositions

Cross-linked polymer particles

Method and process for the production of multi-coated recognitive and releasing systems

Encapsulated Active Ingredients, Methods of Preparation and Their Use

Colonic delivery of metallo-dependent enzymes

Enteric Coated Azithromycin Multiparticulates

Extended-release dosage form

Enteric Coated Didanosine Compositions Having A Subcoat

Composition and method of stabilized sensitive ingredient

Microparticles containing a H+,K+-ATP-ase inhibitor

Compositions and methods for treating or preventing imflammatory diseases

CO-BEADLET OF DHA AND ROSEMARY AND METHODS OF USE

Modified release dosage forms of amoxicillin

Modified release analgesic suspensions

Compositions and methods for treating or preventing inflammatory diseases

Minicapsule Formulations

Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor

Topiramate compositions and methods of enhancing its bioavailability

PHARMACEUTICAL FORMULATION WITH ENHANCED SOLUBILITY FOR THE DELIVERY OF CORTICOSTEROIDS

Controlled release system and method for manufacturing the same

Multi-Layered Controlled-Release Methylphenidate Pellet

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

Fast release dosage forms for antibiotics

Composition For An Enteric Coating Of Natural Product Containing Lectin

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

Pharmaceutical form having a two-layer separating layer

Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof

Method for producing core-shell (CS) particles and microcapsules using porous templates, CS particles and microcapsules, and the use thereof

Combination Products

Microcapsule with Controllable or Delayed Release for the Immobilization of Chemical and/or Biological Materials, and Method for the Production Thereof

Dihydropyrimidine Formulations

Method for forming microcapsules with multiple shell layers

ENTERIC COATED PARTICLES CONTAINING AN ACTIVE INGREDIENT

Enteric coated granule and method for preparing the same

Delivery of ophthalmologic agents to the exterior or interior of the eye

Methods and compositions for the treatment of viral infections

Multimicroparticulate pharmaceutical forms for oral administration

Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

Nutritional Food and Feed, Compostition, Processing and Method of Use

Oral Dosage Formulations and Methods of Preparing the Same

Oral Dosage Formulations and Methods of Preparing the Same

Hollow microspheres with controlled fragility for medical use

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

Multi-membrane immunoisolation system for cellular transplant

Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof

Remote Control Release of Encapsulated Material

EFFERVESCENT FORMULATIONS COMPRISING DESMOPRESSIN

Oral pharmaceutical compositions with controlled release and prolonged absorption

Tamper resistant dosage form comprising an adsorbent and an adverse agent

DUAL-RELEASE COMPOSITIONS OF A CYCLOOXYGENASE-2 INHIBITOR

Pantoprazole multiparticulate formulations

Pantoprazole multiparticulate formulations

DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC SELECTIVE SEROTONIN 5-HT3 BLOCKING AGENT AND ORGANIC ACIDS

Compositions and methods for oxalate reduction

Composition and delivery system

Parathyroid hormone (pth) containing pharmaceutical compositions for oral use

Gastric release pulse system for drug delivery

Use of an intermediate for controlling the release profile of an oral formulation of a medicament

Pharmaceutical composition

Antibiotic compositions

MODIFIED AND PULSATILE RELEASE PHARMACEUTICAL FORMULATIONS OF ESCITALOPRAM

Multi-functional microcapsules and method and device for manufacturing same

Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer

Once-daily administration of central nervous system drugs

Gels for encapsulation of biological materials

Multi-layered coating technology for taste masking

Delayed release pharmaceutical formulations

Sustained-release formulation and uses thereof

Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents

Nanocell drug delivery system

Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof

Pantoprazole multiparticulate formulations

Gastric acid secretion inhibiting composition

Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate

Drug delivery device

Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly

Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly

Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly

Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level

SURFACE-MODIFIED MICROPARTICLES AND METHODS OF FORMING AND USING THE SAME

Multi-component vitamin and mineral supplement for the optimal absorption of components

Timed, pulsatile release systems

Hollow microspheres with controlled fragility for medical use

Coating composition

Dosage form containing (s)-pantoprazole as active ingredient

Multi-particulate, modified-release composition

Controlled release compositions of gamma-hydroxybutyrate

Bisphosphonates for the treatment of atherosclerosis and device comprising them

Dosage form for treating gastrointestinal disorders

Spheroids, preparation method thereof and pharmaceutical compositions

Drug composition having active ingredient adhered at high concentration to spherical core

Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Method and composition for stable and controlled delivery of (-)-hydroxycitric acid

Composition comprising a mixture of active principles, and method of preparation

Solid dosage form comprising proton pump inhibitor and suspension made thereof

Health food product

Multifunctional polymeric tissue coatings

Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion

Micropellets method for the production thereof, and use thereof

Gastric acid secretion inhibiting composition

Venlafaxine compositions comprising pellets with double layer coating

Material encapsulation system

Formulations of [1,4]diazepino[6,7,1-IJ]quinoline derivatives

Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

Method of providing customized drug delivery systems

Ruminant feed pellet composition with controlled release of physiologically active substances, and procedure for preparation and use thereof

Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof

Method of microencapsulation

Stable pharmaceutical formulations of benzimidazole compounds

Means of delivering drugs in an ascending zero order release pattern

Composition comprising a benzimidazole and process for its manufacture

Solid oral dosage form containing seamless microcapsules

Controlled release preparation

Controlled phase composition technology as an improved process for protection of drugs

Method for coating living cells

Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility

Particles for the delivery of active agents

Drug delivery product and methods

Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate

Compressed tablets comprising microcapsules with modified release

Pharmaceutical compositions for the coordinated delivery of NSAIDs

Compositions and methods for treating or preventing inflammatory diseases

Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist

Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist

Medicament storage and delivery devices

Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release

Multiparticulate O-desmethylvenlafaxine salts and uses thereof

Co-beadlet of dha and rosemary and methods of use

Method of treatment for improved bioavailability

Semi-permeable microcapsule with covalently linked layers and method for producing same

Enhanced absorption of modified release dosage forms

Pantoprazole multiparticulate formulations

Compositions of quaternary ammonium compounds containing bioavailability enhancers

Microcapsules containing biomedical materials

Microcapsules and oral composition containing the same

Timed pulsatile drug delivery systems

Combination of polyvinyl acetate with water-insoluble, acid-insoluble, or alkali-insoluble polymers used for the production of film coatings with highly controlled release and high stability

Novel methods of treatment and deliver modes

Antibiotic clarithromycin micropellet compositions

Taste masking antibiotic composition

Extended release formulations of opioids and method of use thereof

Microcapsules having multiple shells and method for the preparation thereof

Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof

Bioadhesive drug delivery system with enhanced gastric retention

Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Antibiotic product, use and formulation thereof

Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

Pharmaceutical compositions having a swellable coating

In vivo use of water absorbent polymers

In vivo use of water absorbent polymers

Composition of matter comprising particles which contain choline chloride to be administered in a rumen protected and post-ruminally effective form

Functional powders for oral delivery

Controlled release potassium chloride tablets

Hollow microspheres with controlled fragility for medical use

Coated zeolitic imidazolate framework (ZIF-8) as an efficient carrier for the Cycloheptylamine hydrochloride for the treatment of diabetes

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Method to provide consistent product batches active components for alkaloids of kratom plants

Extended release pharmaceutical composition of Clozapine

Reduced permeability microcapsules

Method of preparing rosemary nanoparticles and encapsulated rosemary nanoparticles

Pharmaceutical product comprising a sequestered agent